Data / Form D filings / Sagent Holding Co.
Sagent Holding Co.: Form D filings
Sagent Holding Co., a pharmaceuticals company in Schaumburg, IL, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on September 14, 2010, reports $6 million sold of a $6 million offering to 2 investors.
Find out what Sagent Holding Co. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1901 NORTH ROSELLE ROAD, SUITE 700, Schaumburg, IL, 60195
- Phone
- (847) 908-1604
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Cayman Islands
- Year incorporated
- 2006
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1369786
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2010 | New notice | $5,999,998 | $5,999,998 | $0 | 2 | Sep 3, 2010 | sec.gov |
| Apr 5, 2010 | New notice | $9,800,000 | $9,800,000 | $0 | 1 | Mar 24, 2010 | sec.gov |
| Jun 2, 2009 | New notice | $30,000,000 | $30,000,000 | $0 | 10 | May 19, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Sperans | Director | |
| Frank Kung | Director | |
| Anthony Krizman | Director | |
| Chen Yu | Director | |
| Ronald Pauli | Executive Officer | |
| Mark Qiu | Director | |
| Jeffrey Yordon | Executive Officer, Director | |
| Robert Flanagan | Director |
Every Form D from the week of Sep 13, 2010 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sagent Holding Co. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.